Perioperative management for the obese outpatient

Current Opinion in Anaesthesiology

Volumn 27, Issue 6, 2014, Pages 576-582

  Abdullah, Hairil R ^a,b   Chung, Frances ^c  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ambulatory surgery; Obese; Perioperative

Indexed keywords

ATRACURIUM BESILATE; CISATRACURIUM; FENTANYL; MORPHINE; PARACETAMOL; PROPOFOL; REMIFENTANIL; ROCURONIUM; SUXAMETHONIUM;

AMBULATORY SURGERY; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; CARDIOVASCULAR DISEASE; DRUG DISTRIBUTION; DRUG METABOLISM; ENDOCRINE DISEASE; HUMAN; LEAN BODY WEIGHT; MORBID OBESITY; OBESITY; OBESITY HYPOVENTILATION SYNDROME; OUTPATIENT; PATIENT ASSESSMENT; PATIENT SELECTION; PERIOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUESTIONNAIRE; REGIONAL ANESTHESIA; RESPIRATION CONTROL; REVIEW; SLEEP DISORDERED BREATHING; PROCEDURES;

AMBULATORY SURGICAL PROCEDURES; HUMANS; OBESITY; OUTPATIENTS; PERIOPERATIVE CARE;

EID: 84927968976     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000129     Document Type: Review

References (72)

1. Standards Committee American Society for Bariatric Surgery. Guidelines for reporting results in bariatric surgery. Standards Committee American Society for Bariatric Surgery. Obes Surg 1997; 7:521-522.
2. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009-2010. NCHS Data Brief 2012; 82:1-8.
3. Greenstein AJ, Wahed AS, Adeniji A, et al. Prevalence of adverse intra-operative events during obesity surgery and their sequelae. J Am Coll Surg 2012; 215:271-277.
4. Joshi GP, Ahmad S, Riad W, et al. Selection of obese patients undergoing ambulatory surgery: a systematic review of the literature. Anesth Analg 2013; 117:1082-1091.
5. Fortier J, Chung F, Su J. Unanticipated admission after ambulatory surgery: a prospective study. Can J Anaesth 1998; 45:612-619.
6. Memtsoudis SG, Ma Y, Swamidoss CP, et al. Factors influencing unexpected disposition after orthopedic ambulatory surgery. J Clin Anesth 2012; 24:89-95.
7. Chung F, Mezei G, Tong D. Preexisting medical conditions as predictors of adverse events in day-case surgery. Br J Anaesth 1999; 83:262-270.
8. Flum DR, Belle SH, King WC, et al. Perioperative safety in the longitudinal assessment of bariatric surgery. N Eng J Med 2009; 361:445-454.
9. Kakarla VR, Nandipati K, Lalla M, et al. Are laparoscopic bariatric procedures safe in superobese (BMI >50 kg/m2) patients? An NSQIP data analysis. Surg Obes Relat Dis 2011; 7:452-458.
10. Poirier P, Alpert MA, Fleisher LA, et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association. Circulation 2009; 120:86-95.
11. Livingston EH, Langert J. The impact of age and Medicare status on bariatric surgical outcomes. Arch Surg 2006; 141:1115-1120.
12. Karason K, Lindroos AK, Stenlöf K, Sjöström L. Relief of cardiorespiratory symptoms and increased physical activity after surgically induced weight loss: results from the Swedish obese subjects study. Arch Intern Med 2000; 160:1797-1802.
13. Minocci A, Guzzaloni G, Marzullo P, et al. Abdominal fat index by ultrasound does not estimate the metabolic risk factors of cardiovascular disease better than waist circumference in severe obesity. Diabetes Metab 2005; 31:471-477.
14. Drapeau V, Lemieux I, Richard D, et al. Waist circumference is useless to assess the prevalence of metabolic abnormalities in severely obese women. Obes Surg 2007; 17:905-909.
15. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100:1043-1049.
16. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2007; 116:e418-e500.
17. Gallagher MJ, Franklin BA, Ehrman JK, et al. Comparative impact of morbid obesity vs. heart failure on cardiorespiratory fitness. Chest 2005; 127:2197-2203.
18. Parameswaran K, Todd DC, Soth M. Altered respiratory physiology in obesity. Can Respir J 2006; 13:203-210.
19. Lopez PP, Stefan B, Schulman CI, Byers PM. Prevalence of sleep apnea in morbidly obese patients who presented for weight loss surgery evaluation: more evidence for routine screening for obstructive sleep apnea before weight loss surgery. Am Surg 2008; 74:834-838.
20. Rao A, Tey BH, Ramanlingam G, Poh AG. Obstructive sleep apnea (OSA) in bariatric surgical practice and response of OSA to weight loss after laparo-scopic adjustable gastric banding (LAGB). Ann Acad Med Singapore 2009; 38:587-593.
21. Stierer TL, Wright C, George A, et al. Risk assessment of obstructive sleep apnea in a population of patients undergoing ambulatory surgery. J Clin Sleep Med 2010; 6:467-472.
22. American Society of Anesthesiologists: practice Guidelines for the Peri-operative Management of Patients with Obstructive Sleep Apnea. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: an Updated Report by the American Society of Anesthesiologists Task Force on perioperative management of patients with obstructive sleep apnea. Anesthesiology 2014; 120:268-286.
23. Chung F, Yang Y, Liao P. Predictive performance of the STOP-Bang score for identifying obstructive sleep apnea in obese patients. Obes Surg 2013; 23:2050-2057.
24. Olson A, Zwillich C. The obesity hypoventilation syndrome. Am J Med 2005; 118:948-956.
25. Mokhlesi B. Obesity hypoventilation syndrome: a state-of-the-art review. Respir Care 2010; 55:1347-1362.
26. Chau E, Lam D, Wong J, et al. Obesity hypoventilation syndrome: a review of epidemiology, pathophysiology, and perioperative considerations. Anesthe-siology 2012; 117:188-205.
27. Chau E, Mokhlesi B, Chung F. Obesity hypoventilation syndrome and anesthesia. Sleep Med Clin 2013; 8:135-147.
28. Mokhlesi B, Tulaimat A, Faibussowitsch I, et al. Obesity hypoventilation syndrome: prevalence and predictors in patients with obstructive sleep apnea. Sleep Breath 2007; 11:117-124.
29. Kheterpal S, Healy D, Aziz MF, et al. Incidence, predictors, and outcome of difficult mask ventilation combined with difficult laryngoscopy: a report from the multicenter perioperative outcomes group. Anesthesiology 2013; 119:1360-1369.
30. Fox WT, Harris S, Kennedy NJ. Prevalence of difficult intubation in a bariatric population, using the beach chair position. Anaesthesia 2008; 63:1339-1342.
31. Lundstrom LH, Moller AM, Rosenstock C, et al. High body mass index is a weak predictor for difficult and failed tracheal intubation: a cohort study of 91, 332 consecutive patients scheduled for direct laryngoscopy registered in the Danish Anesthesia Database. Anesthesiology 2009; 110:266-274.
32. Ezri T, Medalion B, Weisenberg M, et al. Increased body mass index per se is not a predictor of difficult laryngoscopy. Can J Anesth 2003; 50:179-183.
33. Cook TM, MacDougall-Davis SR. Complications and failure of airway management. Br J Anaesth 2012; 109:i68-i85.
34. Cook TM, Woodall N, Frerk C; Fourth National Audit Project. Major complications of airway management in the UK: results of the fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 1: anaesthesia. Br J Anaesth 2011; 106:617-631.
35. Peterson GN, Domino KB, Caplan RA, et al. Management of the difficult airway: a closed claims analysis. Anesthesiology 2005; 103:33-39.
36. Ramachandran SK, Mathis MR, Tremper KK, et al. Predictors and clinical outcomes from failed laryngeal mask airway UniqueTM: a study of 15, 795 patients. Anesthesiology 2012; 116:1217-1226.
37. Wong DT, Yang JJ, Jagannathan N. Brief review: the LMA SupremeTM supraglottic airway. Can J Anesth 2012; 59:483-493.
38. Murphy C, Wong DT. Airway management and oxygenation in obese patients. Can J anesth 2013; 60:929-945.
39. Narayan KMV, Boyle JP, Thompson TJ, et al. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007; 30:1562-1566.
40. Bailey CJ, Day C. Fixed-dose single tablet antidiabetic combinations. Diabetes Obes Met 2009; 11:527-533.
41. Ferrari LR. New insulin analogues and insulin delivery devices for the perioperative management of diabetic patients. Curr Opin Anesthesiol 2008; 21:401-405.
42. Joshi GP, Chung F, Ahmad S, et al. Society for Ambulatory Anesthesia. Society for Ambulatory Anesthesia consensus statement on perioperative blood glucose management in diabetic patients undergoing ambulatory surgery. Anesth Analg 2010; 111:1378-1387.
43. Umpierrez GE, Latif K, Stoever J, et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 2004; 117:291-296.
44. Nazar CE, Lacassie HJ, Lopez RA, Munoz HR. Dexamethasone for postoperative nausea and vomiting prophylaxis: effect on glycaemia in obese patients with impaired glucose tolerance. Eur J Anaesthesiol 2009; 26:318-321.
45. Ruiz-Tovar J, Boix E, Galindo I, et al. Evolution of subclinical hypothyroidism and its relation with glucose and triglycerides levels in morbidly obese patients after undergoing sleeve gastrectomy as bariatric procedure. Obes Surg 2014; 24:791-795.
46. Boyce JR, Ness T, Castroman P, Gleysteen JJ. A preliminary study of the optimal anesthesia positioning for the morbidly obese patient. Obes Surg 2003; 13:4-9.
47. Dixon BJ, Dixon JB, Carden JR, et al. Preoxygenation is more effective in the 25 degrees head-up position than in the supine position in severely obese patients. Anesthesiology 2005; 102:1110-1115.
48. Altermatt FR, Munoz HR, Delfino AE, Cortinez LI. Preoxygenation in the obese patient: Effects of position on tolerance to apnoea. Br J Anaesth 2005; 95:706-709.
49. Levitan RM, Mechem CC, Ochroch EA, et al. Head-elevated laryngoscopy position: Improving laryngeal exposure during laryngoscopy by increasing head elevation. Ann Emerg Med 2003; 41:322-330.
50. Benumof JL. Preoxygenation: Best method for both efficacy and efficiency. Anesthesiology 1999; 91:603-605.
51. Baraka AS, Taha SK, Siddik-Sayyid SM, et al. Supplementation of pre-oxygenation in morbidly obese patients using nasopharyngeal oxygen insufflation. Anaesthesia 2007; 62:769-773.
52. Gander S, Frascarolo P, Suter M, et al. Positive end-expiratory pressure during induction of general anesthesia increases duration of non-hypoxic apnea in morbidly obese patients. Anesth Analg 2005; 100:580-584.
53. Delay JM, Sebbane M, Jung B, et al. The effectiveness of noninvasive positive pressure ventilation to enhance preoxygenation in morbidly obese patients: a randomized controlled study. Anesth Analg 2008; 107:1707-1713.
54. Bellamy MC, Margarson MP. Designing intelligent anesthesia for a changing patient demographic: a consensus statement to provide guidance for specialist and nonspecialist anesthetists written by members of and endorsed by the Society for Obesity and Bariatric Anaesthesia. Perioper Med (Lond) 2013; 2:12.
55. Freid EB. The rapid sequence induction revisited: obesity and sleep apnea syndrome. Anesthesiol Clin North America 2005; 2:551-564.
56. Ingrande J, Lemmens HJM. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth 2010; 105 (S1):i16-i23.
57. Janmahasatian S, Duffull SB, Ash S, et al. Quantification of lean bodyweight. Clin Pharmacokinet 2005; 44:1051-1065.
58. Ingrande J, Brodsky JB, Lemmens HJ. Lean body weight scalar for the anesthetic induction dose of propofol in morbidly obese subjects. Anesth Analg 2011; 113:57-62.
59. Cortinez LI, Anderson BJ, Penna A, et al. Influence of obesity on propofol pharmacokinetics: Derivation of a pharmacokinetic model. Br J Anaesth 2010; 105:448-456.
60. Shibutani K, Inchiosa MA Jr, Sawada K, Bairamian M. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Br J Anaesth 2005; 95:377-383.
61. Bjorkman S, Wada DR, Stanski DR. Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients. Anesthesiology 1998; 88:657-667.
62. Egan TD, Huizinga B, Gupta SK, et al. Remifentanil pharmacokineticsin obese versus lean patients. Anesthesiology 1998; 89:562-573.
63. Lemmens HJ, Brodsky JB. The dose of succinylcholine in morbid obesity. Anesth Analg 2006; 102:438-442.
64. Leykin Y, Pellis T, Lucca M, et al. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg 2004; 99:1086-1089.
65. Leykin Y, Pellis T, Lucca M, et al. The effects of cisatracurium on morbidly obese women. Anesth Analg 2004; 99:1090-1094.
66. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, et al. Anthropometric variables as predictors for duration of action of atracurium-induced neuro-muscular block. Anesth Analg 1996; 83:1076-1080.
67. DeBaerdemaeker LEC, Mortier EP, Struys MMRF. Pharmacokinetics in obese patients. Contin Educ Anaesth Crit Care Pain 2004; 4:152-155.
68. Abdullah HR, Chung F. Postoperative issues: Discharge criteria. Anesth Clin 2014; 32:487-493.
69. Aldrete JA. The postanesthetic recovery score revisited. J Clin Anesth 1995; 7:89-91.
70. Chung F. Recovery pattern and home-readiness after ambulatory surgery. Anesth Analg 1995; 80:896-902.
71. Seet E, Chung F. Management of sleep apnea in adults-Functional algorithms for the perioperative period: Continuing Professional Development. Can J Anesth 2010; 57:849-864.
72. Wani S, Azar R, Hovis CE, et al. Obesity as a risk factor for sedation-related complications during propofol-mediated sedation for advanced endoscopic procedures. Gastrointest Endosc 2011; 74:1238-1247.